Trends in invasive disease due to Candida species following heart and lung transplantation

Transplant Infectious Disease

Volumn 11, Issue 2, 2009, Pages 112-121

  Schaenman, Joanna ^a,c   Rosso, F ^a   Austin, J M ^a   Baron, E J ^a   Gamberg, P ^a   Miller, J ^a   Oyer, P E ^a   Robbins, R C ^a   Montoya, J G ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PALO ALTO MEDICAL FOUNDATION RESEARCH INSTITUTE   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

Candidiasis; Heart transplantation; Heart lung transplantation; Immunosuppression; Lung transplantation

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIVIRUS AGENT; AZATHIOPRINE; CASPOFUNGIN; CEFAMANDOLE; CEFAZOLIN; COTRIMOXAZOLE; CYCLOSPORIN A; CYTOMEGALOVIRUS ANTIBODY; DACLIZUMAB; ERYTHROMYCIN; GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; ITRACONAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; RAPAMYCIN; THYMOCYTE ANTIBODY; VORICONAZOLE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDIASIS; CHILD; CYTOMEGALOVIRUS INFECTION; DEMOGRAPHY; FEMALE; HEART LUNG TRANSPLANTATION; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KAPLAN MEIER METHOD; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; AGED; ANTIFUNGAL AGENTS; CALIFORNIA; CANDIDA; CANDIDIASIS; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; FEMALE; HEART TRANSPLANTATION; HEART-LUNG TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; INFANT; INFANT, NEWBORN; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; YOUNG ADULT;

EID: 64249106195     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2009.00364.x     Document Type: Article

References (32)

1. Hibberd PL, Rubin RH. Clinical aspects of fungal infection in organ transplant recipients. Clin Infect Dis 1994 19 : S33 S40.
2. Montoya JG, Chaparro SV, Celis D, et al. Invasive aspergillosis in the setting of cardiac transplantation. Clin Infect Dis 2003 37 : S281 S292.
3. Kubak BM. Fungal infection in lung transplantation. Transpl Infect Dis 2002 4 : 24 31.
4. Kanj SS, Welty-Wolf K, Madden J, et al. Fungal infections in lung and heart-lung transplant recipients. Report of 9 cases and review of the literature. Medicine (Baltimore) 1996 75 : 142 156.
5. Dauber JH, Paradis IL, Dummer JS. Infectious complications in pulmonary allograft recipients. Clin Chest Med 1990 11 : 291 308.
6. Dummer JS, Montero CG, Griffith BP, Hardesty RL, Paradis IL, Ho M. Infections in heart-lung transplant recipients. Transplantation 1986 41 : 725 729.
7. Montoya JG, Giraldo LF, Efron B, et al. Infectious complications among 620 consecutive heart transplant patients at Stanford University Medical Center. Clin Infect Dis 2001 33 : 629 640.
8. Singh N. Fungal infections in the recipients of solid organ transplantation. Infect Dis Clin North Am 2003 17 : 113 134.
9. Haron E, Vartivarian S, Anaissie E, Dekmezian R, Bodey GP. Primary Candida pneumonia. Experience at a large cancer center and review of the literature. Medicine (Baltimore) 1993 72 : 137 142.
10. Rose HD, Sheth NK. Pulmonary candidiasis. A clinical and pathological correlation. Arch Intern Med 1978 138 : 964 965.
11. Nunley DR, Gal AA, Vega JD, Perlino C, Smith P, Lawrence EC. Saprophytic fungal infections and complications involving the bronchial anastamosis following human lung transplantation. Chest 2002 122 : 1185 1191.
12. Wisplinghoff H, Bischoff T, Tallent SM, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004 39 : 309 317.
13. Messer SA, Jones RN, Fritsche TR. International surveillance of Candida spp. and Aspergillus spp. from the SENTRY Antimicrobial Surveillance Program (2003). J Clin Microbiol 2006 44 : 1782 1787.
14. Cuenca-Estrella M, Rodriguez D, Almirante B, et al. In vitro susceptibilities of bloodstream isolates of Candida species to six antifungal agents: results from a population-based active surveillance programme, Barcelona, Spain, 2002-2003. J Antimicrob Chemother 2005 55 : 194 199.
15. Pfaller MA, Diekema DJ, Jones RN, et al. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. J Clin Microbiol 2001 39 : 3254 2359.
16. Nguyen MH, Peacock JE Jr., Morris AJ, et al. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am J Med 1996 100 : 617 623.
17. Marr KA. The changing spectrum of candidemia in oncology patients: therapeutic implications. Curr Opin Infect Dis 2000 13 : 615 620.
18. Danziger-Isakov LA, Sweet S, Delamorena M, Huddleston CB, Mendeloff E, Debaun MR. Epidemiology of bloodstream infections in the first year after pediatric lung transplantation. Pediatr Infect Dis J 2005 24 : 324 330.
19. Husain S, Tollemar J, Dominguez EA, et al. Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled study. Transplantation 2003 75 : 2023 2029.
20. Dummer JS, Lazariashvilli N, Barnes J, Ninan M, Milstone AP. A survey of anti-fungal management in lung transplantation. J Heart Lung Transplant 2004 23 : 1376 1381.
21. Robbins RC, Barlow CW, Oyer PE, et al. Thirty years of cardiac transplantation at Stanford University. J Thorac Cardiovasc Surg 1999 117 : 939 951.
22. Moffatt SD, Demers P, Robbins RC, et al. Lung transplantation: a decade of experience. J Heart Lung Transplant 2005 24 : 145 151.
23. Hartwig MG, Davis RD. Surgical considerations in lung transplantation: transplant operation and early postoperative management. Resp Care Clin 2004 10 : 473 504.
24. Miniati DN, Robbins RC. Heart transplantation: a thirty-year perspective. Ann Rev Med 2002 53 : 189 205.
25. Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002 34 : 7 14.
26. Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med 1998 338 : 1741 1751.
27. Snydman DR. Infection in solid organ transplantation. Transpl Infect Dis 1999 1 : 21 28.
28. Patel JK, Kobashigawa JA. Cardiac transplant experience with cyclosporine. Transplant Proc 2004 36 : 323S 330S.
29. Parekh K, Trulock E, Patterson GA. Use of cyclosporine in lung transplantation. Transplant Proc 2004 36 : 318S 322S.
30. Speich R, van der Bij W. Epidemiology and management of infections after lung transplantation. Clin Infect Dis 2001 33 : S58 S65.
31. Ben-Abraham R, Keller N, Teodorovitch N, et al. Predictors of adverse outcome from candidal infection in a tertiary care hospital. J Infect 2004 49 : 317 323.
32. Safdar A, Bannister TW, Safdar Z. The predictors of outcome in immunocompetent patients with hematogenous candidiasis. Int J Infect Dis 2004 8 : 180 186.